If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Humalog®
- Full Prescribing Information
Humalog® U-100 (insulin lispro injection)
100 units/mL - Full Prescribing Information
Humalog® U-200 (insulin lispro injection)
200 units/mL - Full Prescribing Information
Humalog® MIX50/50™ (50% insulin lispro protamine suspension 50% insulin lispro injection [rDNA origin])
100 units/mL - Full Prescribing Information
Humalog® MIX75/25™ (75% insulin lispro protamine suspension 25% insulin lispro injection [rDNA origin])
100 units/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
HUMALOG® MIX: Pediatric Use
Humalog premixed insulin has not been studied in pediatric patients.
The safety and effectiveness of LM75/25 or LM50/50 in patients less than 18 years of age have not been studied.1,2
Enclosed Prescribing Information
HUMALOG® Mix75/25™ (insulin lispro protamine and insulin lispro injectable suspension), for subcutaneous use, Lilly
1. Humalog Mix75/25 [package insert]. Indianapolis, IN: Eli Lilly and Company; 2018.
2. Humalog Mix50/50 [package insert]. Indianapolis, IN: Eli Lilly and Company; 2018.
Glossary
LM50/50 = Humalog® Mix50/50 (insulin lispro protamine and insulin lispro injectable suspension)
LM75/25 = Humalog® Mix75/25 (insulin lispro protamine and insulin lispro injectable suspension)
Date of Last Review: October 31, 2018
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST
